00720
| 00720_Reductive carboxylate cycle (CO2 fixation)
| 0.51
| 25
| 49
| 0.18
| 0.43
| 24
| 131
| Evidence Read_Count
|
00410
| 00410_beta-Alanine metabolism
| 0.31
| 11
| 36
| 0.14
| 0.38
| 10
| 69
| Evidence Read_Count
|
00680
| 00680_Methane metabolism
| 0.30
| 25
| 84
| 0.10
| 0.44
| 29
| 305
| Evidence Read_Count
|
00920
| 00920_Sulfur metabolism
| 0.38
| 11
| 29
| 0.19
| 0.35
| 12
| 64
| Evidence Read_Count
|
00603
| 00603_Glycosphingolipid biosynthesis - globo series
| 0.20
| 2
| 10
| 0.08
| 0.24
| 2
| 25
| Evidence Read_Count
|
00601
| 00601_Glycosphingolipid biosynthesis - lacto and neolacto series
| 0.00
| 0
| 48
| 0.00
| 0.00
| 0
| 39
| Evidence Read_Count
|
00600
| 00600_Sphingolipid metabolism
| 0.05
| 2
| 37
| 0.03
| 0.33
| 2
| 65
| Evidence Read_Count
|
00604
| 00604_Glycosphingolipid biosynthesis - ganglio series
| 0.09
| 2
| 22
| 0.09
| 0.18
| 2
| 22
| Evidence Read_Count
|
00550
| 00550_Peptidoglycan biosynthesis
| 0.73
| 16
| 22
| 0.23
| 0.30
| 13
| 56
| Evidence Read_Count
|
00311
| 00311_Penicillin and cephalosporin biosynthesis
| 0.13
| 2
| 15
| 0.07
| 0.23
| 2
| 28
| Evidence Read_Count
|
00310
| 00310_Lysine degradation
| 0.14
| 7
| 51
| 0.06
| 0.38
| 7
| 109
| Evidence Read_Count
|
00010
| 00010_Glycolysis / Gluconeogenesis
| 0.60
| 31
| 52
| 0.18
| 0.45
| 25
| 136
| Evidence Read_Count
|
00250
| 00250_Alanine, aspartate and glutamate metabolism
| 0.57
| 24
| 42
| 0.23
| 0.43
| 23
| 102
| Evidence Read_Count
|
00253
| 00253_Tetracycline biosynthesis
| 0.06
| 1
| 16
| 0.10
| 0.35
| 2
| 20
| Evidence Read_Count
|
00540
| 00540_Lipopolysaccharide biosynthesis
| 0.38
| 10
| 26
| 0.16
| 0.26
| 9
| 57
| Evidence Read_Count
|
00910
| 00910_Nitrogen metabolism
| 0.34
| 16
| 47
| 0.13
| 0.36
| 22
| 169
| Evidence Read_Count
|
00140
| 00140_Steroid hormone biosynthesis
| 0.10
| 13
| 133
| 0.03
| 0.18
| 2
| 73
| Evidence Read_Count
|
00750
| 00750_Vitamin B6 metabolism
| 0.30
| 10
| 33
| 0.18
| 0.39
| 7
| 38
| Evidence Read_Count
|
00300
| 00300_Lysine biosynthesis
| 0.49
| 18
| 37
| 0.22
| 0.37
| 16
| 72
| Evidence Read_Count
|
00020
| 00020_Citrate cycle (TCA cycle)
| 0.71
| 20
| 28
| 0.21
| 0.47
| 16
| 76
| Evidence Read_Count
|
00380
| 00380_Tryptophan metabolism
| 0.18
| 14
| 77
| 0.10
| 0.38
| 12
| 116
| Evidence Read_Count
|
00904
| 00904_Diterpenoid biosynthesis
| 0.00
| 0
| 66
| 0.00
| 0.00
| 0
| 79
| Evidence Read_Count
|
00905
| 00905_Brassinosteroid biosynthesis
| 0.00
| 0
| 25
| 0.00
| 0.00
| 0
| 11
| Evidence Read_Count
|
00906
| 00906_Carotenoid biosynthesis
| 0.04
| 4
| 99
| 0.03
| 0.14
| 2
| 72
| Evidence Read_Count
|
00900
| 00900_Terpenoid backbone biosynthesis
| 0.35
| 16
| 46
| 0.14
| 0.36
| 13
| 90
| Evidence Read_Count
|
00901
| 00901_Indole alkaloid biosynthesis
| 0.00
| 0
| 20
| 0.00
| 0.00
| 0
| 29
| Evidence Read_Count
|
00902
| 00902_Monoterpenoid biosynthesis
| 0.07
| 3
| 43
| 0.05
| 0.25
| 3
| 57
| Evidence Read_Count
|
00903
| 00903_Limonene and pinene degradation
| 0.13
| 7
| 54
| 0.17
| 0.33
| 6
| 35
| Evidence Read_Count
|
00908
| 00908_Zeatin biosynthesis
| 0.07
| 1
| 15
| 0.06
| 0.41
| 1
| 17
| Evidence Read_Count
|
00909
| 00909_Sesquiterpenoid biosynthesis
| 0.00
| 0
| 75
| 0.00
| 0.00
| 0
| 129
| Evidence Read_Count
|
00860
| 00860_Porphyrin and chlorophyll metabolism
| 0.22
| 25
| 112
| 0.11
| 0.29
| 20
| 177
| Evidence Read_Count
|
00531
| 00531_Glycosaminoglycan degradation
| 0.15
| 3
| 20
| 0.07
| 0.18
| 2
| 29
| Evidence Read_Count
|
00532
| 00532_Glycosaminoglycan biosynthesis - chondroitin sulfate
| 0.12
| 1
| 8
| 0.03
| 0.03
| 1
| 30
| Evidence Read_Count
|
00534
| 00534_Glycosaminoglycan biosynthesis - heparan sulfate
| 0.00
| 0
| 3
| 0.00
| 0.00
| 0
| 25
| Evidence Read_Count
|
00430
| 00430_Taurine and hypotaurine metabolism
| 0.19
| 4
| 21
| 0.10
| 0.45
| 4
| 40
| Evidence Read_Count
|
00740
| 00740_Riboflavin metabolism
| 0.36
| 8
| 22
| 0.15
| 0.39
| 8
| 52
| Evidence Read_Count
|
00660
| 00660_C5-Branched dibasic acid metabolism
| 0.16
| 3
| 19
| 0.10
| 0.29
| 3
| 30
| Evidence Read_Count
|
00331
| 00331_Clavulanic acid biosynthesis
| 0.00
| 0
| 7
| 0.00
| 0.00
| 0
| 9
| Evidence Read_Count
|
00330
| 00330_Arginine and proline metabolism
| 0.45
| 52
| 115
| 0.19
| 0.39
| 44
| 229
| Evidence Read_Count
|
00980
| 00980_Metabolism of xenobiotics by cytochrome P450
| 0.03
| 2
| 76
| 0.05
| 0.20
| 2
| 40
| Evidence Read_Count
|
00981
| 00981_Insect hormone biosynthesis
| 0.00
| 0
| 23
| 0.00
| 0.00
| 0
| 21
| Evidence Read_Count
|
00982
| 00982_Drug metabolism - cytochrome P450
| 0.12
| 6
| 48
| 0.07
| 0.20
| 2
| 28
| Evidence Read_Count
|
00983
| 00983_Drug metabolism - other enzymes
| 0.60
| 18
| 30
| 0.26
| 0.36
| 11
| 42
| Evidence Read_Count
|
00130
| 00130_Ubiquinone and other terpenoid-quinone biosynthesis
| 0.25
| 16
| 63
| 0.12
| 0.31
| 9
| 72
| Evidence Read_Count
|
00232
| 00232_Caffeine metabolism
| 0.00
| 0
| 37
| 0.00
| 0.00
| 0
| 18
| Evidence Read_Count
|
00230
| 00230_Purine metabolism
| 0.61
| 88
| 144
| 0.14
| 0.40
| 51
| 352
| Evidence Read_Count
|
00231
| 00231_Puromycin biosynthesis
| 0.00
| 0
| 10
| 0.00
| 0.00
| 0
| 10
| Evidence Read_Count
|
00030
| 00030_Pentose phosphate pathway
| 0.48
| 21
| 44
| 0.19
| 0.38
| 18
| 96
| Evidence Read_Count
|
00970
| 00970_Aminoacyl-tRNA biosynthesis
| 0.73
| 24
| 33
| 0.24
| 0.50
| 23
| 96
| Evidence Read_Count
|
00522
| 00522_Biosynthesis of 12-, 14- and 16-membered macrolides
| 0.02
| 1
| 63
| 0.02
| 0.01
| 1
| 43
| Evidence Read_Count
|
00523
| 00523_Polyketide sugar unit biosynthesis
| 0.12
| 4
| 32
| 0.10
| 0.45
| 4
| 40
| Evidence Read_Count
|
00520
| 00520_Amino sugar and nucleotide sugar metabolism
| 0.39
| 47
| 120
| 0.16
| 0.35
| 38
| 231
| Evidence Read_Count
|
00521
| 00521_Streptomycin biosynthesis
| 0.53
| 9
| 17
| 0.25
| 0.27
| 9
| 36
| Evidence Read_Count
|
00524
| 00524_Butirosin and neomycin biosynthesis
| 0.04
| 1
| 26
| 0.03
| 0.12
| 1
| 36
| Evidence Read_Count
|
00281
| 00281_Geraniol degradation
| 0.20
| 4
| 20
| 0.12
| 0.26
| 3
| 24
| Evidence Read_Count
|
00280
| 00280_Valine, leucine and isoleucine degradation
| 0.60
| 27
| 45
| 0.17
| 0.36
| 16
| 95
| Evidence Read_Count
|
00770
| 00770_Pantothenate and CoA biosynthesis
| 0.55
| 17
| 31
| 0.23
| 0.40
| 14
| 62
| Evidence Read_Count
|
00670
| 00670_One carbon pool by folate
| 0.55
| 18
| 33
| 0.24
| 0.47
| 12
| 51
| Evidence Read_Count
|
00440
| 00440_Phosphonate and phosphinate metabolism
| 0.04
| 1
| 27
| 0.03
| 0.29
| 1
| 38
| Evidence Read_Count
|
00120
| 00120_Primary bile acid biosynthesis
| 0.04
| 2
| 52
| 0.03
| 0.10
| 1
| 37
| Evidence Read_Count
|
00040
| 00040_Pentose and glucuronate interconversions
| 0.32
| 21
| 65
| 0.15
| 0.44
| 17
| 114
| Evidence Read_Count
|
00960
| 00960_Tropane, piperidine and pyridine alkaloid biosynthesis
| 0.04
| 1
| 28
| 0.04
| 0.41
| 2
| 52
| Evidence Read_Count
|
00965
| 00965_Betalain biosynthesis
| 0.00
| 0
| 8
| 0.00
| 0.00
| 0
| 10
| Evidence Read_Count
|
00351
| 00351_1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation
| 0.00
| 0
| 6
| 0.00
| 0.00
| 0
| 5
| Evidence Read_Count
|
00350
| 00350_Tyrosine metabolism
| 0.19
| 18
| 93
| 0.08
| 0.24
| 10
| 123
| Evidence Read_Count
|
00643
| 00643_Styrene degradation
| 0.19
| 4
| 21
| 0.05
| 0.27
| 2
| 37
| Evidence Read_Count
|
00642
| 00642_Ethylbenzene degradation
| 0.08
| 1
| 13
| 0.05
| 0.34
| 1
| 22
| Evidence Read_Count
|
00640
| 00640_Propanoate metabolism
| 0.40
| 20
| 50
| 0.15
| 0.42
| 17
| 111
| Evidence Read_Count
|
00290
| 00290_Valine, leucine and isoleucine biosynthesis
| 0.83
| 20
| 24
| 0.30
| 0.45
| 9
| 30
| Evidence Read_Count
|
00513
| 00513_High-mannose type N-glycan biosynthesis
| 0.08
| 1
| 13
| 0.02
| 0.09
| 1
| 43
| Evidence Read_Count
|
00512
| 00512_O-Glycan biosynthesis
| 0.00
| 0
| 10
| 0.00
| 0.00
| 0
| 18
| Evidence Read_Count
|
00510
| 00510_N-Glycan biosynthesis
| 0.00
| 0
| 35
| 0.00
| 0.00
| 0
| 77
| Evidence Read_Count
|
00592
| 00592_alpha-Linolenic acid metabolism
| 0.36
| 9
| 25
| 0.06
| 0.34
| 2
| 31
| Evidence Read_Count
|
00591
| 00591_Linoleic acid metabolism
| 0.00
| 0
| 12
| 0.00
| 0.00
| 0
| 29
| Evidence Read_Count
|
00590
| 00590_Arachidonic acid metabolism
| 0.02
| 1
| 43
| 0.02
| 0.35
| 1
| 63
| Evidence Read_Count
|
00760
| 00760_Nicotinate and nicotinamide metabolism
| 0.29
| 15
| 52
| 0.14
| 0.33
| 12
| 87
| Evidence Read_Count
|
00450
| 00450_Selenoamino acid metabolism
| 0.68
| 13
| 19
| 0.24
| 0.42
| 11
| 45
| Evidence Read_Count
|
00052
| 00052_Galactose metabolism
| 0.56
| 28
| 50
| 0.16
| 0.35
| 16
| 101
| Evidence Read_Count
|
00053
| 00053_Ascorbate and aldarate metabolism
| 0.22
| 10
| 46
| 0.09
| 0.45
| 7
| 76
| Evidence Read_Count
|
00051
| 00051_Fructose and mannose metabolism
| 0.34
| 23
| 68
| 0.13
| 0.42
| 18
| 138
| Evidence Read_Count
|
00791
| 00791_Atrazine degradation
| 0.06
| 1
| 16
| 0.05
| 0.66
| 1
| 22
| Evidence Read_Count
|
00790
| 00790_Folate biosynthesis
| 0.68
| 19
| 28
| 0.21
| 0.31
| 9
| 43
| Evidence Read_Count
|
00950
| 00950_Isoquinoline alkaloid biosynthesis
| 0.02
| 1
| 66
| 0.01
| 0.42
| 1
| 92
| Evidence Read_Count
|
00650
| 00650_Butanoate metabolism
| 0.33
| 17
| 51
| 0.14
| 0.32
| 17
| 118
| Evidence Read_Count
|
00340
| 00340_Histidine metabolism
| 0.43
| 15
| 35
| 0.21
| 0.43
| 15
| 72
| Evidence Read_Count
|
01055
| 01055_Biosynthesis of vancomycin group antibiotics
| 0.08
| 1
| 12
| 0.03
| 0.45
| 1
| 30
| Evidence Read_Count
|
01057
| 01057_Biosynthesis of type II polyketide products
| 0.00
| 0
| 88
| 0.00
| 0.00
| 0
| 67
| Evidence Read_Count
|
01056
| 01056_Biosynthesis of type II polyketide backbone
| 0.00
| 0
| 18
| 0.00
| 0.00
| 0
| 17
| Evidence Read_Count
|
00500
| 00500_Starch and sucrose metabolism
| 0.43
| 35
| 82
| 0.18
| 0.32
| 30
| 170
| Evidence Read_Count
|
01058
| 01058_Acridone alkaloid biosynthesis
| 0.00
| 0
| 3
| 0.00
| 0.00
| 0
| 5
| Evidence Read_Count
|
00062
| 00062_Fatty acid elongation in mitochondria
| 0.62
| 21
| 34
| 0.09
| 0.26
| 3
| 34
| Evidence Read_Count
|
00061
| 00061_Fatty acid biosynthesis
| 0.53
| 28
| 53
| 0.20
| 0.36
| 9
| 45
| Evidence Read_Count
|
00710
| 00710_Carbon fixation in photosynthetic organisms
| 0.68
| 19
| 28
| 0.23
| 0.45
| 14
| 61
| Evidence Read_Count
|
00460
| 00460_Cyanoamino acid metabolism
| 0.20
| 8
| 40
| 0.07
| 0.46
| 4
| 55
| Evidence Read_Count
|
00260
| 00260_Glycine, serine and threonine metabolism
| 0.43
| 28
| 65
| 0.17
| 0.38
| 25
| 143
| Evidence Read_Count
|
00100
| 00100_Steroid biosynthesis
| 0.00
| 0
| 47
| 0.00
| 0.00
| 0
| 49
| Evidence Read_Count
|
00780
| 00780_Biotin metabolism
| 0.43
| 10
| 23
| 0.18
| 0.35
| 7
| 39
| Evidence Read_Count
|
00785
| 00785_Lipoic acid metabolism
| 1.00
| 6
| 6
| 0.43
| 0.41
| 3
| 7
| Evidence Read_Count
|
00940
| 00940_Phenylpropanoid biosynthesis
| 0.08
| 5
| 65
| 0.04
| 0.54
| 2
| 52
| Evidence Read_Count
|
00941
| 00941_Flavonoid biosynthesis
| 0.00
| 0
| 69
| 0.00
| 0.00
| 0
| 39
| Evidence Read_Count
|
00942
| 00942_Anthocyanin biosynthesis
| 0.00
| 0
| 40
| 0.00
| 0.00
| 0
| 18
| Evidence Read_Count
|
00943
| 00943_Isoflavonoid biosynthesis
| 0.00
| 0
| 53
| 0.00
| 0.00
| 0
| 29
| Evidence Read_Count
|
00944
| 00944_Flavone and flavonol biosynthesis
| 0.00
| 0
| 43
| 0.00
| 0.00
| 0
| 43
| Evidence Read_Count
|
00945
| 00945_Stilbenoid, diarylheptanoid and gingerol biosynthesis
| 0.00
| 0
| 20
| 0.00
| 0.00
| 0
| 19
| Evidence Read_Count
|
00563
| 00563_Glycosylphosphatidylinositol(GPI)-anchor biosynthesis
| 0.00
| 0
| 9
| 0.00
| 0.00
| 0
| 27
| Evidence Read_Count
|
01040
| 01040_Biosynthesis of unsaturated fatty acids
| 0.00
| 0
| 21
| 0.00
| 0.00
| 0
| 7
| Evidence Read_Count
|
00471
| 00471_D-Glutamine and D-glutamate metabolism
| 0.55
| 6
| 11
| 0.22
| 0.38
| 4
| 18
| Evidence Read_Count
|
00472
| 00472_D-Arginine and D-ornithine metabolism
| 0.30
| 3
| 10
| 0.20
| 0.17
| 2
| 10
| Evidence Read_Count
|
00473
| 00473_D-Alanine metabolism
| 0.50
| 3
| 6
| 0.27
| 0.35
| 3
| 11
| Evidence Read_Count
|
04070
| 04070_Phosphatidylinositol signaling system
| 0.18
| 5
| 28
| 0.05
| 0.09
| 3
| 62
| Evidence Read_Count
|
00625
| 00625_Tetrachloroethene degradation
| 0.28
| 9
| 32
| 0.09
| 0.33
| 4
| 45
| Evidence Read_Count
|
00624
| 00624_1- and 2-Methylnaphthalene degradation
| 0.09
| 5
| 56
| 0.04
| 0.34
| 2
| 50
| Evidence Read_Count
|
00627
| 00627_1,4-Dichlorobenzene degradation
| 0.05
| 4
| 80
| 0.03
| 0.18
| 4
| 116
| Evidence Read_Count
|
00626
| 00626_Naphthalene and anthracene degradation
| 0.07
| 3
| 44
| 0.05
| 0.08
| 2
| 40
| Evidence Read_Count
|
00621
| 00621_Biphenyl degradation
| 0.08
| 2
| 26
| 0.06
| 0.49
| 2
| 35
| Evidence Read_Count
|
00620
| 00620_Pyruvate metabolism
| 0.43
| 30
| 69
| 0.18
| 0.45
| 25
| 137
| Evidence Read_Count
|
00623
| 00623_2,4-Dichlorobenzoate degradation
| 0.09
| 4
| 43
| 0.05
| 0.14
| 4
| 74
| Evidence Read_Count
|
00622
| 00622_Toluene and xylene degradation
| 0.16
| 6
| 37
| 0.06
| 0.34
| 3
| 47
| Evidence Read_Count
|
00270
| 00270_Cysteine and methionine metabolism
| 0.55
| 41
| 75
| 0.21
| 0.40
| 28
| 135
| Evidence Read_Count
|
00830
| 00830_Retinol metabolism
| 0.08
| 2
| 24
| 0.04
| 0.23
| 2
| 50
| Evidence Read_Count
|
00071
| 00071_Fatty acid metabolism
| 0.64
| 30
| 47
| 0.14
| 0.30
| 11
| 78
| Evidence Read_Count
|
00072
| 00072_Synthesis and degradation of ketone bodies
| 0.50
| 3
| 6
| 0.21
| 0.50
| 3
| 14
| Evidence Read_Count
|
00401
| 00401_Novobiocin biosynthesis
| 0.04
| 1
| 27
| 0.04
| 0.41
| 2
| 45
| Evidence Read_Count
|
00400
| 00400_Phenylalanine, tyrosine and tryptophan biosynthesis
| 0.49
| 21
| 43
| 0.15
| 0.36
| 16
| 104
| Evidence Read_Count
|
00402
| 00402_Benzoxazinoid biosynthesis
| 0.12
| 1
| 8
| 0.00
| 0.00
| 0
| 17
| Evidence Read_Count
|
00730
| 00730_Thiamine metabolism
| 0.23
| 5
| 22
| 0.14
| 0.33
| 5
| 37
| Evidence Read_Count
|
00360
| 00360_Phenylalanine metabolism
| 0.22
| 14
| 65
| 0.10
| 0.30
| 13
| 127
| Evidence Read_Count
|
00361
| 00361_gamma-Hexachlorocyclohexane degradation
| 0.10
| 7
| 72
| 0.04
| 0.18
| 3
| 69
| Evidence Read_Count
|
00362
| 00362_Benzoate degradation via hydroxylation
| 0.12
| 9
| 76
| 0.07
| 0.36
| 10
| 142
| Evidence Read_Count
|
00363
| 00363_Bisphenol A degradation
| 0.06
| 1
| 18
| 0.07
| 0.01
| 1
| 14
| Evidence Read_Count
|
00364
| 00364_Fluorobenzoate degradation
| 0.12
| 3
| 26
| 0.03
| 0.06
| 1
| 29
| Evidence Read_Count
|
00930
| 00930_Caprolactam degradation
| 0.22
| 4
| 18
| 0.14
| 0.21
| 4
| 29
| Evidence Read_Count
|
01051
| 01051_Biosynthesis of ansamycins
| 0.05
| 1
| 19
| 0.03
| 0.46
| 1
| 33
| Evidence Read_Count
|
00633
| 00633_Trinitrotoluene degradation
| 0.06
| 1
| 16
| 0.07
| 0.28
| 2
| 28
| Evidence Read_Count
|
00630
| 00630_Glyoxylate and dicarboxylate metabolism
| 0.32
| 24
| 76
| 0.15
| 0.41
| 21
| 142
| Evidence Read_Count
|
00564
| 00564_Glycerophospholipid metabolism
| 0.16
| 12
| 74
| 0.07
| 0.20
| 10
| 143
| Evidence Read_Count
|
00565
| 00565_Ether lipid metabolism
| 0.00
| 0
| 26
| 0.00
| 0.00
| 0
| 48
| Evidence Read_Count
|
00562
| 00562_Inositol phosphate metabolism
| 0.15
| 8
| 53
| 0.05
| 0.31
| 5
| 92
| Evidence Read_Count
|
01053
| 01053_Biosynthesis of siderophore group nonribosomal peptides
| 0.00
| 0
| 4
| 0.00
| 0.00
| 0
| 34
| Evidence Read_Count
|
00561
| 00561_Glycerolipid metabolism
| 0.20
| 8
| 41
| 0.07
| 0.35
| 7
| 104
| Evidence Read_Count
|
00240
| 00240_Pyrimidine metabolism
| 0.64
| 74
| 116
| 0.17
| 0.39
| 38
| 229
| Evidence Read_Count
|
00480
| 00480_Glutathione metabolism
| 0.25
| 13
| 51
| 0.11
| 0.48
| 8
| 76
| Evidence Read_Count
|